Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
Clinical trial NCT05018286 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05018286
- Sponsor
- VectivBio AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-13
- Primary completion
- 2027-10-30
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.